We are developing the next generation of Soft Mist InhalersAbout us
Softhale is developing pharmaceutical inhalation products for major respiratory markets in the USA, Europe, and Asia. These products are based upon a differentiated inhalation delivery technology called SOFTHALER®. This device is a next-generation Soft Mist Inhaler (SMI) which offers a platform technology for delivering various drugs to the lungs. As well as generic products, innovative products are also targeted.
Based in Diepenbeek, Belgium, Softhale N.V. is a pharmaceutical company specializing in the development of inhalable respiratory products for the medical treatment of various indications.More
Meet our Team of Experts
As a group, our Board offers profound medical, pharmaceutical/chemical, medical device, and consumer product expertise. It consists of members of the Series A & B multi-national venture capital consortium, the CEO, a non-executive director, a founder’s representative, and the chairman.Meet our team